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The five countries with the highest HIV prevalence rates in the
world are situated in southern Africa, and South Africa, with
an estimated 4.7 million people living with HIV, has more cases
of HIV/AIDS than any other country.1 The impact of the
epidemic on all sectors of society, from urban industries to
rural villages, is already being felt and will worsen as more
people progress from asymptomatic HIV to AIDS. Information
on the extent and distribution of HIV is vital for planning and
is the main reason why workplaces, institutions and sectors
such as public service, health and education are conducting
HIV seroprevalence studies. 
Until recently, few national community-based HIV surveys
had been undertaken.  Instead, most estimates on general
prevalence had been extrapolated from annual antenatal
surveys. While the antenatal survey has been useful in
determining trends over time, it is less reliable for generating
population-level estimates.2,3 This is because the study
population consists of pregnant women who use public sector
health services.  It therefore excludes pregnant women who use
private health care, women who are not pregnant, and all men
and children. Antenatal surveys in South Africa yield data that
can be generalised to 1.8 million pregnant women per year,
while population-based surveys generalise to an estimated 44.5
million people.4
The Nelson Mandela/Human Sciences Research Council
(HSRC) study of HIV/AIDS5 is the first study of HIV
prevalence data drawn from the whole population aged 2 years
and older. In addition, data on demographic, socio-economic
and behavioural risk factors associated with HIV provide a
detailed picture of the distribution and determinants of this
devastating epidemic.
Methods
A complex, multi-stage random sample of 1 000 census
enumerator areas (EAs) was drawn from a total of 86 000 such
areas.  From these EAs, clusters of 11 visiting points were
identified from census maps and aerial photographs. Of the 
10 197 households selected, 7 249 (71.1%) were included in the
study.
A census of all persons over the age of 2 years was taken for
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Objective. To determine HIV prevalence in the South African
population and to investigate risk factors for HIV.
Methods. A national sample of  10 197 households was
selected.  One child (aged 2 - 14 years), one youth (15 - 24
years) and one adult (25 years and older) were randomly
selected from each household.  Consenting respondents were
interviewed about their socio-demographic characteristics
and asked to give an oral mucosal transudate sample to test
anonymously for HIV. 
Differential response rates were compared using
unweighted data. The Orasure HIV-1 device in combination
with the Vironostika HIV UNI-Form II plus O enzyme-linked
immunosorbent assay kits were used to collect oral fluid
specimens for HIV testing.   HIV prevalence within
subgroups was compared using Rao and Scott’s adjusted chi-
square. Relative risk was calculated using Poisson regression.
All analysis was on the weighted data.
Results.  Of the 10 197 households selected, 7 249 (71.1%) were
included in the study.  Of the 13 518 individuals selected, 
9 963 (73.7%) were interviewed.  Of these, 8 428 (62.3%)
agreed to HIV testing and had valid results.  
HIV prevalence in the general population was 11.4% (12.8%
in females and 9.5% in males).  Blacks had the highest
prevalence (12.9%), compared with whites (6.2%), coloureds
(6.1%) and Indians (1.6%).  Informal settlements in urban
areas had the highest HIV prevalence (21.6%). 
The findings of this study are consistent with South African
Department of Health estimates based on the 2002 antenatal
survey.
Conclusion. The Nelson Mandela/Human Sciences Research
Council survey included all race, sex and age groups. It is
therefore the most reliable and valid source of information on
the extent and distribution of the HIV epidemic in South
Africa.
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each household, and 1 child (aged 2 - 14 years), 1 youth 
(15 - 24 years) and 1 adult (25 years and older) living in each
household were randomly selected.  HIV prevalence in these
three age groups was of particular interest. Children were
included because little is known about HIV prevalence in
children. Youth were chosen because the United Nations
General Assembly HIV indicator adopted globally is to
measure a reduction in HIV infection among the youth, defined
as those aged 15 - 24 years.  The remaining persons aged 25
years and older reflects HIV status in the adult population.
Three questionnaires were designed, with some overlapping
questions and some specific to each age group.  Retired nurses
were trained as data collectors and were matched culturally
with the community in which they were working.  The Orasure
HIV-1 oral specimen collection device in combination with the
Vironostika HIV UNI-Form II plus O enzyme-linked immuno-
sorbent assay (ELISA) kits were used to determine HIV status.
There was no repeat on positive HIV tests.  This is in line with
the World Health Organisation (WHO) strategy designed for
populations where HIV prevalence is over 10%.
Ethical approval was obtained from the HSRC.  Written
informed consent was obtained from all participants over the
age of 14 years and verbal assent was obtained from children
aged 2 - 14 years.    
Of the 13 518 individuals selected, 9 963 (73.7%) were
interviewed.  Of these, 8 428 agreed to HIV testing and had
valid results.  A more detailed description of the methodology
and analysis of non-response has been reported in a previous
paper.6 
Demographic data were collected for all sampled individuals
as part of the household census. Table I presents the
demographic characteristics of persons refusing both the
questionnaire and HIV test, those refusing HIV testing only,
and those who were fully compliant.  The most common
reasons for non-participation were: (i) not willing to participate
in any survey (25%); (ii) not available now (17%); (iii) too busy
to grant an interview (8.8%); (iv) apprehensive about a saliva
sample being taken (8.2%); and (v) objection to the topic of the
survey, viz. HIV/AIDS (4.5%).  Non-participation rates were
Table I.  Comparison of characteristics of non-participants (those refusing both questionnaire and HIV testing) and respondents (those
agreeing to both questionnaire and HIV testing) (all ages)
Non-participants Participants who refused HIV testing Fully compliant respondents
N % N % N %
Age group (yrs)
2 - 14 851 22.8 531 14.2 2 348 63.0 
15 - 24 1 029 29.8 329 9.5 2 099 60.7
25 - 49 1 178 27.3 443 10.3 2 696 62.5
50+ 497 24.7 232 11.5 1 285 63.8
Sex
Male 1 833 29.1 704 11.2 3 772 59.8
Female 1 722 23.9 831 11.5 4 656 64.6
Race
Black 1 875 24.0 871 11.2 5 056 64.8
White 634 42.0 176 11.7 701 46.4
Coloured 613 23.5 221 8.5 1 775 68.0
Indian 433 27.1 267 16.7 896 56.1
Locality type
Rural (tribal) 666 23.4 367 12.9 1 818 63.8
Rural (farm) 185 22.0 84 10.0 572 68.0
Urban (formal) 2 255 27.2 946 11.4 5 103 61.5
Urban (informal) 449 29.5 138 9.1 935 61.4
Province
Western Cape 486 26.9 56 3.1 1 267 70.0
Eastern Cape 389 20.8 265 14.1 1 221 65.1
Northern Cape 184 20.2 35 3.8 694 76.0
Free State 184 22.9 81 10.1 540 67.1
KwaZulu-Natal 620 23.5 445 16.8 1 579 59.7
North West 306 29.4 110 10.6 626 60.1
Gauteng 612 28.6 255 11.9 1 272 59.5
Mpumalanga 410 39.8 70 6.8 550 53.4
Limpopo 364 28.9 218 17.3 679 53.8
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higher among persons aged 15 - 24 and lower among those
aged 2 - 14.  Refusal to participate was more frequent among
males, whites and persons in Mpumalanga province.  This is
likely to reflect problems of accessibility and absenteeism in
spite of repeat visits to the household.   
Persons who agreed to be interviewed but who refused an
HIV test represent a greater potential bias because the reason
for refusal may have been linked to HIV status. These data
have been presented by Shisana et al.,6 who conclude that while
differences in demographic factors exist, the reasons given for
test refusal were not related to HIV status. More importantly
there were no differences between participants and non-
participants in behavioural risk factors associated with HIV. 
Statistical analysis
Differential non-response was analysed using unweighted
data.   Prevalence rates were calculated using weighted data.
The sampling weight was a product of the EA, household and
individual sampling weights and was adjusted for non-
response.  Standard error calculations used procedures that
account for stratification and clustering in the survey design.
HIV prevalence in subgroups was compared using Rao and
Scott’s adjusted chi-square.7 Relative risk (RR) was calculated
using Poisson regression on the unweighted data.  The 95%
confidence intervals (CIs) reported are based on a logit
transformation and are not symmetrical. A multivariable
logistical model was used to identify independent risk factors
associated with HIV.
Results
HIV seroprevalence in the population of persons aged 2 years
and older was estimated to be 11.4% (CI: 10.0 - 12.7).  Women
had a significantly higher HIV prevalence rate than men (RR:
1.3, CI: 1.1 - 1.6, p = 0.005), as shown in Table II.  
Blacks were more likely to be HIV-positive than whites (RR
2.0, CI: 1.3 - 3.3), coloureds (RR 2.0, CI: 1.4 - 3.3) or Indians (RR:
10, CI: 2.5 - 25).  Indians had significantly lower HIV
prevalence than any other racial group (Table II).
Within racial groups, black females were at greater risk than
black males (RR: 1.3, CI: 1.1 - 1.7).  While females of other racial
groups had higher prevalence rates than males of the same
race, the difference did not reach statistical significance (RR:
1.2, CI: 0.7 - 2.1). As shown in Fig. 1, HIV prevalence peaked in
women aged 20 - 29 years (24.1%), and in men at age 30 - 39
(21.3%).  Of the 244 women who had been pregnant in the last
12 months, 24% were HIV-positive (CI: 16.5 - 33.6).  The age
distribution of the pregnant women was similar to that of
women in the 2002 antenatal survey (DOH, 2003).
Informal settlements in urban areas showed the highest HIV
prevalence rate when compared with urban formal areas (RR
1.8, CI: 1.7 - 3.5), rural informal areas (RR 2.5, CI: 1.7 - 3.5) or
rural formal areas (RR 2.8, CI: 1.7 -  4.4), as shown in Table III.
Women living in rural areas had a similar HIV prevalence rate
to men (Table III) (RR: 1.2, CI: 0.8 - 1.6), whereas women in
urban areas had significantly higher HIV levels than men (RR:
1.4, CI: 1.1 - 1.9). Informal areas are areas with limited
infrastructure and shack-like housing.
HIV prevalence varied significantly by province, from 6.6%
in the Eastern Cape to 14.9% in the Free State (Fig. 2). The CIs
of the top four provinces overlap, suggesting that the
differences are not statistically significant.
When age, sex, race and residence were entered in a
multivariable logistical model, all factors remained statistically
significant.  However when the data were stratified by race
(black versus other racial groups), the risk factors remained
significant only in the black racial group (p-value for sex =
Table II. HIV prevalence by race and sex, ages 2 - 99 years
Male Female Total
N % 95% CI N % 95% CI N % 95% CI
Black 2 229 10.8 9.0 - 12.8 2 827 14.5 12.4 - 16.8 5 056 12.9 11.3 - 14.6
White 334 5.2 2.6 - 9.8 367 7.0 3.6 - 13.3 701 6.2 3.7 - 10.0
Coloured 788 5.5 3.8 - 7.9 987 6.6 4.1 - 10.3 1 175 6.1 4.5 - 8.3
Indian 421 2.7 0.6 - 11.1 475 0.6 0.2 - 1.9 896 1.6 0.5 - 5.0
Total 3 772 9.5 8.1 - 11.2 4 656 12.8 11.0 - 14.7 8 428 11.4 10.1 - 12.7
40
35
30
25
20
15
10
5
0
2 - 9 10 - 19 20 - 29 30 - 39 40 - 49 50+
Age group (yrs)
males
females
H
IV
 p
re
va
le
nc
 (%
)
Fig. 1. Prevalence of HIV by sex and age, South Africa 2002.
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0.052). The main distinction was the lack of an age differential
among other racial groups when compared with the strong
association of age and HIV in blacks.
Discussion
A number of studies1,8-10 have estimated HIV prevalence in
various population groups within South Africa. Each has used
a different methodology.  The 2001 Department of Health10
estimate of HIV prevalence in women aged 15 - 49 years
attending government antenatal clinics was 24.8% (CI: 23.6 -
26.1).  The DOH 200211 estimate was 26.5% (CI: 25.5 - 27.6).  The
Dorrington model,9 which is based on the antenatal figures,
estimated the prevalence in this group to be 25.9%.  The
prevalence among pregnant women in the Nelson
Mandela/HSRC study is again very similar, at 24% 
(CI: 16.5 - 33.6). 
However the population estimate for black and coloured
women aged 15 - 49 years in the Nelson Mandela/HSRC surveys
was much lower, at 19.2% (CI: 16.5 - 22.3). Since the age
distribution of women attending antenatal clinics may be different
from that in the community, the Nelson Mandela/ HSRC rate was
standardised to the age distribution of the antenatal clinic
attendees.  The standardised rate was 21.4% (CI: 20.8 - 22.6) which,
although still lower, is closer to the DOH rate.11 
Rehle and Shisana8 have estimated HIV prevalence in the
adult population (males and females, all races, aged 15 - 49
years). The Nelson Mandela/HSRC survey5 estimated the
prevalence in this age group to be 15.6% (CI: 13.9 - 17.6). Using
the Epi model and Spectrum, Rehle and Shisana estimated the
prevalence to be 17.4% for 2001. The measured prevalence and
the projected prevalence fall within the same confidence
intervals.
Table IV compares the HIV prevalence estimates from the
present study with those of the DOH 2001 antenatal study10
and the  modelled estimates of Dorrington et al.9 by province.
With the exception of the Western Cape, HIV prevalence
estimates from the Nelson Mandela survey are lower than
those of the DOH 2001 study.  The estimates were significantly
lower in KwaZulu-Natal, the Free State and the Eastern Cape,
and higher in the Western Cape.  Standardisation brings the
rates slightly closer but the differences in these  four provinces
remain. 
Table V shows the age-specific prevalence rates.  In women
aged less than 24 years the antenatal rate is higher than the
Nelson Mandela/HSRC rate for black and coloured women
and the antenatal rates for women aged 40 - 44, lower than the
corresponding HSRC rates.
Based on a prevalence of 11.4%, the estimated number of
cases in 2001 is 5.1 million.  This is comparable to the UNAIDS1
estimate of 5 million and that of Rehle and Shisana8 of 4.69
million.  Bearing in mind that the present survey included
persons 2 years or older, the HIV prevalence as estimated is
lower than estimates from other sources such as the projections
based on the Dorrington model (14.2%).9 However adult (15 -
49 years) estimates appear to be closer: Nelson
Mandela/HSRC (15.6%),5 DOH 2001 (19.3%),10 Rehle and
Shisana (17.4%)8 and UNAIDS (20.1%).1 For women aged 
15 - 49, the estimates are slightly closer: Nelson Mandela HSRC
(21.4% standardised; 24% pregnant women)5 and DOH 2001
(24.8%).10 This comparability of data from similar populations
indicates that the Nelson Mandela/HSRC study of HIV/AIDS
data is probably not significantly biased. This is an important
issue because before the Nelson Mandela/HSRC study, all
population-level estimates of the prevalence of HIV were
modelled on antenatal data and extrapolated from pregnant
women to the whole population based on many assumptions.
Fig. 2. HIV prevalence by province in South Africa — Nelson
Mandela/HSRC Study of HIV/AIDS.
Table III.  HIV prevalence by gender and locality type 
Males Females Total
Locality type N % HIV 95% CI N % HIV 95% CI N % 95% CI
Rural formal 298 6.0 3.6 - 9.8 274 9.6 5.3 - 16.4 572 7.8 5.2 - 11.6
Rural informal 729 8.4 6.0 - 11.7 1 089 9.0 6.7 - 12.1 1 818 8.8 6.8 - 11.3
Urban formal 2 266 9.2 7.2 - 11.7 2 837 13.9 11.5 - 16.7 5 103 11.9 10.2 - 13.8
Urban informal 479 17.6 13.0 - 23.5 456 25.5 18.2 - 34.5 935 21.6 17.1 - 26.9
Total 3 772 9.5 8.1 - 11.2 4 656 12.8 11.0 - 14.7 8 428 11.4 10.1 - 12.7
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It is likely that the Nelson Mandela/HSRC data for non-
pregnant women will be more reliable as these data are based
on empirical measurement rather than modelling. Further
work is needed to incorporate the age/race/sex estimates from
this survey to recalibrate and refine existing models. 
The higher HIV prevalence found among young women
participating in the 2002 antenatal survey compared with that
measured among young women in the community and the
opposite finding among older women, may be due to inherent
biases in antenatal data. Antenatal data are likely to
overestimate HIV prevalence in women under 20 because such
data are based only on data from sexually active women who
recently engaged in unprotected sex resulting in pregnancy.2,3
Antenatal data are likely to underestimate HIV prevalence in
the over-30s because fertility is lower among people living with
HIV12 and because of possible voluntary reduction in fertility
among those who know their HIV status.
When considering the association between demographic
variables and HIV infection, race remains an important
predictor variable, with black people being at substantial and
significantly higher risk. However, there is no biological
evidence that particular races are at higher or lower risk and so
the challenge remains to determine the behavioural variables
for which race is a proxy indicator. We hope to provide some
answers in a forthcoming paper investigating the relationships
between demographic, socio-economic and behavioural
variables. 
Apart from limited data from workplace-based studies, there
have been no unbiased data sources on the prevalence of HIV
among whites in South Africa.  This has led to the myth that
HIV is essentially an ‘African’ disease. Our study has shown
that HIV occurs in all race groups and that the prevalence
among whites is the highest documented population-level
prevalence in the world, contrasting starkly with prevalence in
North America, Europe and Australasia where the general
population prevalence is below 1%. 1 A prevalence level of 1%
or higher is also indicative of a generalised, heterosexual
epidemic because epidemics confined to subgroups such as
homosexuals or injecting drug users cannot account for a level
of  6.2% obtained from community-based studies such as ours. 
The finding that more women than men are living with HIV
is compatible with findings from many other studies in sub-
Table IV. Comparison between Nelson Mandela/HSRC5 provincial HIV prevalence estimates and data from the antenatal survey11 and the
modelled estimates of Dorrington et al.9
Estimated (HIV+) Nelson Standardised Dorrington
95% CI for year Mandela/HSRC rate† et al.‡
Province 2001 2001* (%) 2001 (%)
KwaZulu-Natal 33.5 (30.6 - 36.4) 22.1 (16.2 - 29.5) 22.7 34.5 
Mpumalanga 29.2 (25.6 - 32.8) 23.4 (15.9 - 33.3) 24.8  30.2 
Gauteng 29.8 (27.5 - 32.1) 27.7 (20.0 - 37.0) 29.3 25.0 
Free State 30.1 (26.5 - 33.7) 14.6   (8.5 - 24.2) 17.7 28.9 
North West 25.2 (21.9 - 28.6) 18.5 (11.3 - 28.9) 22.1 26.3 
Eastern Cape 21.7 (19.0 - 24.4) 12.0   (8.1 - 17.0) 14.9 23.8 
Limpopo 14.5 (12.2 - 16.9) 11.8   (7.5 - 18.1) 13.7 22.7 
Northern Cape 15.9 (10.1 - 21.6) 11.8   (7.4 - 18.1) 19.4 14.8 
Western Cape 8.6  (5.8 - 11.5) 20.7 (12.0 - 33.4) 23.9 8.4 
National 24.8 (23.6 - 26.1) 19.2 (16.5 - 20.7) 21.4 25.9 
Overall estimates of HIV prevalence, with 95% confidence intervals in brackets.
‡Child-bearing women (15 - 49 years).
*Black and coloured  women (15 - 49 years).
†Nelson Mandela HSRC rates for black and coloured women standardised to the antenatal population.
Table V. Comparison by age band between antenatal data and Nelson Mandela/HSRC data5
Age group Antenatal Nelson Mandela/HSRC data
(yrs) data 2001 Total sample All women Black and coloured women 
15 - 19 15.4 (13.8 - 16.9) 5.9 (4.0 - 8.8) 7.3 (4.7 - 11.3) 8.1 (5.2 - 12.5)
20 - 24 28.4 (26.5 - 30.2) 13.2 (10.4 - 16.7) 17.1 (12.9 - 22.3) 17.5 (13.2 - 22.9)
25 - 29 31.4 (29.5 - 33.3) 28.4 (22.9 - 34.6) 32.0 (24.9 - 40.1) 35.3 (27.4 - 44.1)
30 - 34 25.6 (23.5 - 27.7) 24.1 (19.0 - 30.1) 24.1 (17.3 - 32.5) 27.0 (19.4 - 36.1)
35 - 39 19.3 (17.0 - 21.5) 15.6 (11.2 - 21.3) 13.8 (8.7 - 21.1) 15.5 (9.7 - 23.8)
40 - 44 9.1 (6.2 - 11.9) 16.4 (12.1 - 22.0) 19.0 (12.9 - 27.2) 20.9 (14.0 - 30.0)
45 - 49 17.8 (4.3 - 31.4) 11.5 (7.9 - 16.6) 11.2 (6.5 - 18.7) 11.0 (5.9 - 19.4)
Overall estimates of HIV prevalence, with 95% confidence intervals in brackets.
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Saharan Africa. It is believed that the sex differential in
prevalence reflects a biological, social and behavioural higher
HIV risk among women. The observation that HIV prevalence
peaks earlier in women than men has also been reported
previously and probably reflects the fact that men tend to have
sexual partners younger than themselves.13-15 Data from our
study support this contention in that 11.5% of women had
partners who were 10 years or more older than themselves and
the HIV prevalence in this group was 31.8%
A previously unreported finding is the high prevalence of
HIV in urban informal areas compared with urban formal areas
and rural areas. This is not surprising given the transient
nature of life and lack of social cohesion in such settlements.
Clearly these areas need to be targeted by appropriate HIV
prevention campaigns.
The response rate for the study was lower than we would
have liked. Several operational processes contributed to this
result such as the delay between sampling respondents and
interviews, loss of specimens, and lack of accessibility because
of inclement weather.  These factors can be corrected in future
studies.   However, subgroups refusing HIV testing for
personal or religious reasons remain a concern.  Non-response
in whites was 42.0% compared with 24% in blacks. A higher
proportion of non-responding whites and Indians were ‘not
willing to participate in any survey/interview’.  Fear or lack of
interest could account for their reaction. A higher proportion of
non-responding youth (15 - 24 years) than older people were
‘not available’ at the time of the study, probably reflecting the
mobility of this subgroup.  Special attention needs to be paid to
improving levels of co-operation by increasing HIV awareness
and testing to ensure that future large HIV prevalence surveys
are not negatively affected.
HIV prevalence in two provinces was significantly different
from previous estimates.  The explanation for the lower rates
found in KwaZulu-Natal in this survey compared with the
antenatal survey,11 even after standardisation, may be that in
KwaZulu-Natal the 35 clinics used in the antenatal survey are
all located along main roads which are known to be high
transmission areas.16 Therefore, the results from the KwaZulu-
Natal antenatal survey may overestimate the prevalence.  
The present study found a higher HIV prevalence in the
Western Cape than that found in antenatal data. This may be
because of sampling bias. The antenatal data may not have
included sufficient numbers of people living in informal
settlements and black townships. The high prevalence of HIV
in the Western Cape found in this study corresponds with the
behavioural indicators, which show that youth in that province
have the highest rate of ever having had sex, and the fourth
highest HIV prevalence among youth. Respondents were asked
if they had changed behaviour in the last few years because of
widespread HIV infection. Only 35.2% of residents in the
Western Cape reported behaviour change, which was the
second lowest rate of behaviour change among provinces.  
Other limitations of the survey include the omission of under
2-year-olds and  residents in institutions such as the uniformed
forces and those in university hostels. These omissions did not
significantly alter the findings as shown in the modelling of
HIV/AIDS in South Africa.8 
The Nelson Mandela/HSRC survey5 sampled people from all
walks of life, from different races, age groups, sex groups and
locality type. The strength of the survey is that, for the first
time, prevalence data are available on a sample representing
the whole country.
In conclusion, we believe that the data presented here are the
most reliable and valid source of information for
understanding the extent and distribution of the HIV epidemic
in South Africa. These data will enable researchers and policy
makers from a variety of sectors and institutions to estimate
the prevalence of HIV among their specific populations. 
This study was funded by the Nelson Mandela Foundation,
Nelson Mandela Children’s Fund, Human Sciences Research
Council and the Swiss Agency for Development and Co-operation.
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